Gordon Ralph Corey, MD

Professor of Medicine
Gary Hock Professor in Global Health, in the School of Medicine
Vice-Chair for Education and Global Health in the Department of Medicine
Research Professor of Global Health
Professor of Pathology
Member in the Duke Clinical Research Institute
Campus mail 310 Trent Drive Room 235 Trent, Box 90519, Durham, NC 27708
Phone (919) 668-7174
Email address corey001@mc.duke.edu

My research is based at the Duke Clinical Research Institute, a large academic clinical research organization designed to conduct clinical trials from small local studies to worldwide trials. The focus of my research is bacterial infections: complicated skin and skin structure infections; postoperative wound infections; hospital-acquired and ventilator-associated pneumonia; bacteremia; and endocarditis. Many of these trials are conducted in concert with the pharmaceutical industry in order to register new antibiotics. In addition, as director of infectious diseases at the DCRI I oversee the work of the mycology group, and tuberculosis trials. This work also includes work supported by NIH grants including sepsis trials, the Staph Aureus and Staph Epi Bacteremia Groups, and the International Collaboration of Endocarditis. The team of investigators with whom I work is highly experienced, amazingly productive and wonderfully collegial.

As a result of my longstanding interest in tropical medicine and the generosity of my patients as well as the Hubert Family we have been able to establish the Hubert-Yeargan Center for Global Health. As a result we have developed a medical center-wide fellowship in Global Health. I am presently the Director of the Center and the Gary Hock Distinguished Professor of Global Health.

Education and Training

  • Fellowship, Infectious Diseases, Duke University School of Medicine, 1978 - 1980
  • Chief Resident, General Internal Medicine, Duke University School of Medicine, 1977 - 1978
  • Residency, General Internal Medicine, Duke University School of Medicine, 1975 - 1977
  • Internship, General Internal Medicine, Duke University School of Medicine, 1974 - 1975
  • M.D., Baylor University, 1973

Publications

Bae, In-Gyu, Giang T. Tonthat, Martin E. Stryjewski, Thomas H. Rude, Lindsay F. Reilly, Steven L. Barriere, Fredric C. Genter, G Ralph Corey, and Vance G. Fowler. “Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial..” J Clin Microbiol 47, no. 12 (December 2009): 3952–57. https://doi.org/10.1128/JCM.01643-09.

PMID
19846653
Full Text

Kanafani, Z. A., W. M. Kourany, V. G. Fowler, D. P. Levine, G. A. Vigliani, M. Campion, D. E. Katz, G. R. Corey, and H. W. Boucher. “Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis..” Eur J Clin Microbiol Infect Dis 28, no. 12 (December 2009): 1477–82. https://doi.org/10.1007/s10096-009-0808-3.

PMID
19730900
Full Text

Corey, G Ralph, Martin E. Stryjewski, Wim Weyenberg, Uma Yasothan, and Peter Kirkpatrick. “Telavancin..” Nat Rev Drug Discov 8, no. 12 (December 2009): 929–30. https://doi.org/10.1038/nrd3051.

PMID
19949399
Full Text

Bae, In-Gyu, Jerome J. Federspiel, José M. Miró, Christopher W. Woods, Lawrence Park, Michael J. Rybak, Thomas H. Rude, et al. “Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance..” J Infect Dis 200, no. 9 (November 1, 2009): 1355–66. https://doi.org/10.1086/606027.

PMID
19811099
Full Text

Tripodi, Marie-Françoise, Daniel Vigo, Emanuele Durante-Mangoni, Alberto Lifschitz, G Ralph Corey, Martin E. Stryjewski, Riccardo Utili, Daniel Pryluka, and Daniel International Collaboration on Endocarditis Prospective Cohort Study. “Rhodococcus equi endocarditis in immunocompetent hosts: report of the first two cases..” Int J Antimicrob Agents 34, no. 5 (November 2009): 496–97. https://doi.org/10.1016/j.ijantimicag.2009.06.002.

PMID
19589660
Full Text

Cosgrove, S. E., V. G. Fowler, G. R. Corey, A. W. Karchmer, and H. W. Boucher. “Reply to Bruss.” Clinical Infectious Diseases 49, no. 5 (September 1, 2009): 807–8. https://doi.org/10.1086/605288.

Full Text

Goswami, N. D., J. J. Shah, G. R. Corey, and J. E. Stout. “Short report: Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy.” American Journal of Tropical Medicine and Hygiene 81, no. 2 (August 1, 2009): 302–4.

Scholars@Duke

Nannini, Esteban C., Martin E. Stryjewski, Kavindra V. Singh, Agathe Bourgogne, Tom H. Rude, G Ralph Corey, Vance G. Fowler, and Barbara E. Murray. “Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure..” Antimicrob Agents Chemother 53, no. 8 (August 2009): 3437–41. https://doi.org/10.1128/AAC.00317-09.

PMID
19487449
Full Text

Pages